| NDDs | Neurodevelopmental disorders |
| DSM-5-TR | Statistical manual of mental disorders, fifth edition, text revision |
| ADHD | Attention-deficit/hyperactivity disorder |
| ASD | Autism spectrum disorder |
| ID | Intellectual disability |
| MeSH | Medical subject headings |
| NGF | Nerve growth factor |
| BDNF | Brain-derived neurotrophic factor |
| NT-3 | Neurotrophin-3 |
| NT-4/5 | Neurotrophin-4/5 |
| GDNF | Glial-derived neurotrophic factor |
| p75NTR | p75 neurotrophin receptor |
| Trk receptors | Tyrosine receptor kinases |
| CNS | Central nervous system |
| Ras/MAPK/ERK | Rat sarcoma/mitogen-activated protein kinase/extracellular signal-regulated kinase |
| PI3K/Akt | Phosphoinositide 3-kinase/protein kinase B |
| PLCγ | Phospholipase C gamma |
| VEGF | Vascular endothelial growth factor |
| DRG | Dorsal root ganglia |
| PNS | Peripheral nervous system |
| EEG | Electroencephalogram |
| SNPs | Single nucleotide polymorphisms |
| NSID | Non-syndromic intellectual disability |
| IQ | Intelligence quotient |
| LTP | Long-term potentiation |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin-6 |
| TNF-α | Tumor necrosis factor-α |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| Omega-3 FAs | Omega-3 fatty acids |
| SVZ | Subventricular zone |
| FGF | Fibroblast growth factor |
| EGF | Epidermal growth factor |
| IGF-1 | Insulin-like growth factor |
| HGF | Hepatocyte growth factor |